Auris Medical Holding (EARS) Reports In-Line Q2 Loss
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Auris Medical Holding (NASDAQ: EARS) reported Q2 EPS of (CHF0.25), in-line with the analyst estimate of (CHF0.25).
Cash and cash equivalents at June 30, 2016, totaled CHF 32.8 million, which does not include the $12.5 million received in July 2016 as part of the loan facility.
For earnings history and earnings-related data on Auris Medical Holding (EARS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q3 EPS by 1c; Offers Light Q4 Outlook; Enters New Licensing Agreements
- SeaChange Int'l (SEAC) Tops Q3 EPS by 2c; Guides Q4, FY17 Below Views
- SunPower (SPWR) to Commence Restructuring; Sees Charges; Offers FY17 Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!